Wireless Diabetes Management

Cellnovo launched the world's first and only mobile-connected diabetes management system and started the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes. The trial is also the first to capture all clinical data remotely in real-time using the mobile data connectivity of the Cellnovo system.

The diabetes management system comprises an insulin pump that connects wirelessly to an intuitive "app-based" touchscreen handset. The handset features an integral blood glucose monitor, an activity monitor, and a GSM data connection to a comprehensive Web-based clinical management system.
Cellnovo patients will be able to track and manage their diabetes, securely sharing all clinical information through the Web so that they and their doctors, nurses, and family members can ensure sustained and effective diabetic control.

Type 1 diabetes is routinely managed with pump technology. By introducing a unique system that uses cellular data and touch-screen technology, Cellnovo aims to eliminate the barriers to adoption of insulin pump therapy, simplifying and reducing the workload for doctors and nurses while also improving the quality of insight and diabetes management achieved by patients.